Bladder cancer (BCa) is the most common malignancy of the urinary tract and one of the
most prevalent cancers worldwide. While the clinical approach to BCa has remained largely …

Background Systemic immune-inflammation index (SII) has recently emerged as a
biomarker for the prognosis of a variety of malignant tumors. However, the role of SII in …

Mucin1 (MUC1), a glycoprotein associated with an aggressive cancer phenotype and
chemoresistance, is aberrantly overexpressed in a subset of clear cell renal cell carcinoma …

Urothelial carcinoma (UC), the sixth most common cancer in Western countries, includes
upper tract urothelial carcinoma (UTUC) and bladder carcinoma (BC) as the most common …

Metabolomic analysis has proven to be a useful tool in biomarker discovery and the
molecular classification of cancers. In order to find new biomarkers, and to better understand …

Objectives Although smoking is a well-recognized causative factor of urothelial bladder
cancer and accounts for 50% of cases, less is known about the prognostic significance of …

Background The preoperative systemic immune-inflammation index (SII) is correlated with
prognosis in several malignancies. The aim of this study was to investigate the prognosis …

Background Neutrophil-to-lymphocyte ratio (NLR) has been studied as a biomarker for
cancer prognosis, predicting survival in many tumors. The aim of this umbrella review was to …

Background To date, there has been limited synthesis of RWE studies in high-risk non-
muscle invasive bladder cancer (HR-NMIBC). The objective of this research was to conduct …

Background Non-muscle-invasive bladder cancer (NMIBC) patients receive frequent
monitoring because≥ 70% will have recurrent disease. However, screening is invasive …